REFERENCES:
1. Jalpa G. Patel and Prof. Dr. Dhrubo Jyoti Sen; Synthesis of Prodrug of ester and amide linkages of NSAID having carboxylic acid, phenolic and imino groups: World Journal of Pharmacy and Pharmaceutical Sciences; 2016; 5(11): 897-908.
2. Dhrubo Jyoti Sen and Jalpa G. Patel; Logarithmic partition coefficient comparison study and molecular weight of synthesized Prodrugs of ibuprofen+paracetamol, diclofenac sodium+paracetamol and ibuprofen+diclofenac sodium: American Journal of Advanced Drug Delivery: 2016, 4(05), 064-068.
3. J.E. Slemmer, B.R. Martin and M.I. Damaj. Bupropion is a nicotinic antagonist. J. Pharm. Exp. Ther., 2000; 295: 321–327.
4. C. Wu, J. Quan, J. Xie, C Branford-White, L. Zhu, Y. Yu and Y. Wang. Preparation and controlled release of degradable polymeric ketoprofen-saccharide conjugates. Polym Bull., 2011; 67: 593–608.
5. M, Babazadeh and T. Mosanejhad, Vinyl ester type polymers containing ibuprofen pendents: synthesis, characterization and evaluation. Iran Polym J., 2009; 18: 179–186.
6. L. Shargel, Susanna Wu-Pong and B.C. Andrew, Applied Biopharmaceutics & Pharmacokinetics, 6th Ed.McGraw-Hill Medical Publishing Division, US., 2012; 47-66, 129-154.
7. S. Shirke*, S. Shewale and M. Satpute, Prodrug design: an overview. International Journal of Pharmaceutical, Chemical and Biological Sciences., 2015; 5(1): 232-241.
8. A.V. Bhosale, G.P. Agrawal and P.Mishra: Preparation and Evaluation of Directly Compressible Forms of Mutual Prodrugs of Ibuprofen Forms of Mutual Prodrugs of Ibuprofen. Indian Journal of Pharmaceutical Sciences, 2006; 68(4): 425-431.
9. Beckett AH and Stenlake JB, Practice pharmaceutical chemistry; 4th Edn; CBS Publishers and Distributors, New Delhi, 1997, 293-304.
10. Ewing GW, Instrumental Methods of Chemical Analysis; 5th Edn; McGraw- Hill Book Company, New York, 1985, 1-7.
11. Kasture AV, Mahadik KR, Wadodkar SG and More HN, Instrumental methods of pharmaceutical analysis; 14th Edn; Nirali Prakashan, Pune, 2006, 1-30.
12. Wikipedia: The free Encyclopedia, “Ultraviolet-visible spectroscopy”, 2013, https://en.wikipedia.org/wiki/Ultraviolet-visible spectroscopy.
13. Davidson AG, Practical Pharmaceutical Chemistry; 4th Edn; CBS Publishers and Distributors, 1997, 275-337.
14. Skoog DA, Holler FJ and Nieman TA, Principle of Instrumentation Analysis; 5th Edn; Thomas Asia Pvt Ltd, 2005, 580.
15. Sharma BK, Instrumental Method of Chemical Analysis; 25th Edn; Krishna Prakashan Media Ltd, 2006, 183-186.
16. Beckett AH and Stenlake JB, Practical Pharmaceutical Chemistry; 4th Edn; CBC Publication and distribution, 1977, 1-26.
17. Snyder LR., Kirkland JL and Glajch JL., Practical HPLC Method Development.,2nd Edition, Wiley Interscience, 1977, 1- 26.
18. Halmilton RJ and Sewell PA., Introduction to HPLC., 2nd Edition; Chapman and Hall, 1982, 189.
19. Stability Testing of New Drugs and Product: ICH Q1 A (R2), 2003, 1- 20.
20. Cartensen JT and Rhodes CT., Drug stability: Principles and practices New York – Marcel Dekker; 3rd Edition, 329 – 384.
21. Riley CM and Rosanske TW., Progress in Pharmaceutical and Biomedical Analysis., Development and validation of analytical methods., 1st Edition ; Elsevier Science Ltd, USA, 1996, 133–135.
22. Haynes, W.M. (ed.). CRC Handbook of Chemistry and Physics. 94th Edition. CRC Press LLC, Boca Raton: FL 2013-2014, p. 3-314
23. Yalkowsky, S.H., He, Yan, Jain, P. Handbook of Aqueous Solubility Data Second Edition. CRC Press, Boca Raton, FL 2010, 492.
24. O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK: Royal Society of Chemistry, 2013, 10.
25. American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, 2212.
26. O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001, 876.
27. Yalkowsky SH, Dannenfelser RM; The AQUASOL database of Aqueous Solubility. Ver 5. Tucson, AZ: Univ AZ, College of Pharmacy, 1992.
28. Osol, A. (ed.). Remington's Pharmaceutical Sciences. 16th ed. Easton, Pennsylvania: Mack Publishing Co., 1980, 1057.
29. Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996, 712.
30. Testa, B. and P. Jenner. Drug Metabolism: Chemical & Biochemical Aspects. New York: Marcel Dekker, Inc., 1976, 22.
31. O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006, 522.
32. Finn A et al; Acta Technol Legis Med, 1986, 4: 33-44.
33. American Society of Health-System Pharmacists 2011; Drug Information 2011. Bethesda, MD. 2011, 2113.
34. Anojo Hetal; Eur J Drug Metab Pharmacokinetic, 1999, 24(4): 345-51.
35. Hosale AV, Agrawal GP and Mishra P: Preparation and characterization of mutual Prodrugs of ibuprofen. IJPSR 2004; Vol. 2, Issue 4 ISSN: 0975-8232.
36. Koren, K., Mann, A.R., Colosimo, A.L., Diaz, Z., Nuclelman, A., Levovich, I., Jing, Y., Waxman, S. and Miller, W.H. Jr., Mol. Cancer Res., 2003, 1, 903.
37. Slemmer J.E., Martin B.R., Damaj M.I. Bupropion is a nicotinic antagonist. J. Pharm. Exp. Ther. 2000; 295: 321–327.
38. Wu C, Quan J, Xie J, Branford-White C, Zhu L, Yu Y, Wang Y. Preparation and controlled release of degradable polymeric ketoprofen-saccharide conjugates. Polym Bull. 2011; 67: 593–608.
39. Gennaro, R., Alfanso, W., Remington: The science and practice of pharmacy, Lippincott Williams & Wilkins, 2003, 20, 1, 913-914.
40. Shargel AB and Andrew BC, Applied Biopharmaceutics & Pharmacokinetics, 4th Ed. McGraw-Hill Medical Publishing Division, US. 47-66, 129-154.